Valiant Laboratories

Valiant Laboratories Operating Expenses

The Total Operating Expenses of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 43.50 M INR. In the previous year, Total Operating Expenses was 7.04 M INR — a change of 517.80% (higher).

Operating Expenses

43.50 MINR

YoY

517.80%

Last updated:

Total Operating Expenses of Valiant Laboratories is 2026 43.50 M INR. Total Operating Expenses of Valiant Laboratories was 2025 7.04 M INR. It decreases by 517.80% higher compared to the previous year.

The Valiant Laboratories Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2021
5.55 M INR
Jan 1, 2022
4.77 M INR
Jan 1, 2023
6.53 M INR
Jan 1, 2024
6.55 M INR
Jan 1, 2025
7.04 M INR
Jan 1, 2026
43.50 M INR
The Valiant Laboratories Operating Expenses history
YEAROperating ExpensesYoY
43.50 MINR+517.80%
7.04 MINR+7.43%
6.55 MINR+0.37%
6.53 MINR+36.90%
4.77 MINR-14.05%
5.55 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

Total Operating Expenses of Valiant Laboratories is 43.50 M INR in 2026.

Total Operating Expenses of Valiant Laboratories changed from 7.04 M INR to 43.50 M INR, representing a 517.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Valiant Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Valiant Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Valiant Laboratories